Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Nimrall Laboratories products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Pharmaceutical manufacturer · Islamabad · Pakistan

Islamabad/Rawat pharmaceutical manufacturer producing branded generics across multiple therapeutic and dosage-form categories.

Nimrall Laboratories products in Pakistan

Nimrall Laboratories has 62 medicine presentations registered in Pakistan under 33 brands, covering 32 generic medicines. Most of its products are in Anti-infectives, Respiratory & allergy and Ophthalmology. Its brands with the most registered strengths and packs are Piprocap (Ciprofloxacin), Relyon (Artemether + Lumefantrine, Artemether), Savion (Silver sulfadiazine) and Telizo (Ceftriaxone). 62 products have an official DRAP price on MedInfoBase. See all 33 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation11 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date1 Jul 2024Newest effective date among published current price records
Corporate profile evidence3 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer
Address
Plot No. SS-3, Rawat Industrial Zone, Islamabad 44000, Pakistan · 44000
Phone
+92 51 5565740
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000611 Nimrall Laboratories. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000611 62 linked products · source seen 11 Nov 2026 View source ↗
Corporate profile source ledger Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx67public portfolio records represented
REG56unique registrations represented
IDX62indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+5registry-only registrations
VER25registry-verified exact registrations
PKR62current validated price records
G32generic molecules in indexed catalogue
DF8dosage-form groups
TA7therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage93%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage87%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixNimrall LaboratoriesShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/nimrall-laboratoriesGenerated 11 Nov 2026Anti-infectives46 · 74%Respiratory & allergy4 · 6%Ophthalmology4 · 6%Pain & musculoskeletal4 · 6%Fluids & supportive care2 · 3%Hematology & thrombosis1 · 2%Gastrointestinal & hepatology1 · 2%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioNimrall LaboratoriesDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/nimrall-laboratoriesGenerated 11 Nov 202662presentationsTablet18 · 29%Injection14 · 23%Capsule9 · 15%Cream5 · 8%Drops5 · 8%Suspension5 · 8%Other forms6 · 10%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionNimrall LaboratoriesCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/nimrall-laboratoriesGenerated 11 Nov 202654comparable productsBelow peer median50 · 93%Near peer median2 · 4%Above peer median2 · 4%Company median price position-21.7%Lowest-price equivalents17Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsNimrall LaboratoriesCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/nimrall-laboratoriesGenerated 11 Nov 2026Bosch Pharmaceuticals (Pvt) Ltd.24 shared75% overlapMediate Pharmaceutical Pvt Ltd22 shared69% overlapEpharm Laboratories22 shared69% overlapM/s. Genix Pharma (Pvt) Ltd.21 shared66% overlapAtco Laboratories Limited21 shared66% overlapNeutro Pharma (Pvt.) Ltd.,21 shared66% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives46 products · 74%
Respiratory & allergy4 products · 6%
Ophthalmology4 products · 6%
Pain & musculoskeletal4 products · 6%
Fluids & supportive care2 products · 3%
Hematology & thrombosis1 products · 2%
Gastrointestinal & hepatology1 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Fluoroquinolone antibacterials11 products · 18%
Third-generation cephalosporins6 products · 10%
Antimalarials6 products · 10%
Macrolide antibacterials5 products · 8%
Antihistamines4 products · 6%
Antifungals4 products · 6%
Other systemic antibacterials4 products · 6%
Analgesics / NSAIDs4 products · 6%
Formulation footprint

Dosage forms

Tablet18 products
Injection14 products
Capsule9 products
Cream5 products
Drops5 products
Suspension5 products
Infusion4 products
Syrup2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 PiprocapCiprofloxacin 4presentations 2 mg, 2 mg/mL, 250 mg, 500 mg · Infusion, Capsule #2 SavionSilver sulfadiazine 4presentations 1 %, 10 mg/g (1%) · Cream #3 TelizoCeftriaxone 4presentations 1 g, 250 mg · Injection #4 TescoIbuprofen 4presentations 200 mg, 400 mg · Tablet #5 AzotineAzithromycin 3presentations 200 mg/5 mL, 250 mg, 500 mg · Suspension, Capsule #6 Bi-cipCiprofloxacin 3presentations 250 mg, 250 mg/5 mL, 500 mg · Tablet, Suspension
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Nimrall Laboratories is priced against the market

54 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Bosch Pharmaceuticals (Pvt) Ltd.250 products · 73 generics 24shared generics Mediate Pharmaceutical Pvt Ltd236 products · 89 generics 22shared generics Epharm Laboratories144 products · 67 generics 22shared generics

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers51Distinct registrations among indexed, published, presentation-validated products only
Verified price observations62
Products with a verified price62
Products with multiple price observations0
Source records with multiple versions62
Latest portfolio source check22 Sep 2026
Latest effective price date1 Jul 2024
Latest source observation11 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

56 unique registration(s) · 62 indexed presentation(s) · 5 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Adin Loratadine 5 mg/5 mL Syrup 60ml 054550 PKR 78.70 PKR 1.31/mL 🔒 Pharma Pro
Adin Loratadine 10 mg Tablet 10's 065160 PKR 122.84 PKR 12.28/tablet 🔒 Pharma Pro
Aquanim Water Water for Injection 5 mL Injection 5mlx100's 090191 PKR 1,020.33 PKR 2.04/mL 🔒 Pharma Pro
Aquanim Water Water for Injection 5 mL Injection 5mlx1's 090191 PKR 11.09 PKR 2.22/mL 🔒 Pharma Pro
Azotine Azithromycin 250 mg Capsule 10's 046078 PKR 435.05 PKR 43.51/capsule 🔒 Pharma Pro
Azotine Azithromycin 200 mg/5 mL Dry suspension 15ml 066209 PKR 281.50 PKR 18.77/mL 🔒 Pharma Pro
Azotine Azithromycin 500 mg Capsule 3's 068501 PKR 213.26 PKR 71.09/capsule 🔒 Pharma Pro
Banzapra 10mg TabletRegistry verified Cyclobenzaprine HCl — — — 109671Official source ↗ No indexed price — —
Bi-cip Ciprofloxacin 500 mg Tablet 10's 046075 PKR 443.58 PKR 44.36/tablet 🔒 Pharma Pro
Bi-cip Ciprofloxacin 250 mg Tablet 10's 046256 PKR 221.79 PKR 22.18/tablet 🔒 Pharma Pro
Bi-cip Ciprofloxacin 250 mg/5 mL Dry suspension 60ml 066211 PKR 240.15 PKR 4.00/mL 🔒 Pharma Pro
Cefine Cefixime 400 mg Capsule 5's 060026 PKR 520.25 PKR 104.05/capsule 🔒 Pharma Pro
Cefine Cefixime 100 mg/5 mL Dry suspension 30ml 060027 PKR 290.33 PKR 9.68/mL 🔒 Pharma Pro
Cefine 200mg dry suspensionRegistry verified Cefixime as (Trihydrate) — — — 060028Official source ↗ No indexed price — —
Clyclomed Cyclopentolate 1 % Ophthalmic drops 10ml 072383 PKR 123.44 PKR 12.34/mL No comparator
Clyclomed Cyclopentolate 1% Ophthalmic drops 15ml 072383 PKR 185.17 PKR 12.34/mL No comparator
Exil w / w Terbinafine 1 % Cream 10gm 066232 PKR 269.81 PKR 26.98/g 🔒 Pharma Pro
Fedrox-500 CapsulesRegistry verified Cefadroxil (as Monohydrate USP) — — — 072398Official source ↗ No indexed price — —
Fosine Miltefosine 50 mg Capsule 56's 070117 PKR 27,297.39 PKR 487.45/capsule 🔒 Pharma Pro
Glantan Eye Latanoprost 0.0525 mg/mL Ophthalmic drops 2.5ml 072382 PKR 618.32 PKR 247.33/mL No comparator
Goldspec Moxifloxacin 400 mg Tablet 5's 049027 PKR 712.96 PKR 142.59/tablet 🔒 Pharma Pro
Grell Clopidogrel 75 mg Tablet 10's 046257 PKR 195.13 PKR 19.51/tablet 🔒 Pharma Pro
Hydronim Hydroxychloroquine 200 mg Tablet 50's 106005 PKR 548.91 PKR 10.98/tablet 🔒 Pharma Pro
Hydronim Hydroxychloroquine 200 mg Tablet 30's 106005 PKR 329.35 PKR 10.98/tablet 🔒 Pharma Pro
Klar-500 Clarithromycin 500 mg Capsule 10's 046082 PKR 667.93 PKR 66.79/capsule No comparator
Levox Levofloxacin 250 mg Tablet 10's 046073 PKR 426.52 PKR 42.65/tablet 🔒 Pharma Pro
Levox Levofloxacin 500 mg Tablet 10's 046074 PKR 709.73 PKR 70.97/tablet 🔒 Pharma Pro
Lopenim 200 Lopinavir + Ritonavir 200 mg + 50 mg Tablet 120's 106004 PKR 9,368.06 PKR 78.07/tablet 🔒 Pharma Pro
Lumen Fluconazole 50 mg/5 mL Dry suspension 35ml 066212 PKR 358.28 PKR 10.24/mL 🔒 Pharma Pro
Lunim Fluconazole 2 mg/mL IV infusion 50mlx1's 072390 PKR 494.71 PKR 9.89/mL No comparator
Mepra 20 Omeprazole 20 mg Capsule 14's 046084 PKR 245.68 PKR 17.55/capsule 🔒 Pharma Pro
Mero-M Meropenem 500 mg IV injection 1's 121392 PKR 1,144.90 PKR 1,144.90/vial/unit 🔒 Pharma Pro
Mero-M Meropenem 1 g IV powder for injection 1's 121393 PKR 2,140.00 PKR 2,140.00/vial/unit No comparator
Metzyle Metronidazole (Benzoate) 200 mg Suspension 60ml 054551 PKR 54.32 PKR 0.91/mL No comparator
Metzyle Metronidazole 500 mg IV infusion 100ml 072929 PKR 80.30 PKR 0.80/mL 🔒 Pharma Pro
Nimolol Timolol 0.5 % Ophthalmic drops 5ml 072922 PKR 135.09 PKR 27.02/mL 🔒 Pharma Pro
Nimstat Nystatin 100,000 IU Tablet 3x5's 066693 PKR 57.09 PKR 3.81/tablet No comparator
Nimzine Cetirizine 10 mg Tablet 10's 052610 PKR 40.61 PKR 4.06/tablet 🔒 Pharma Pro
Nimzine Cetirizine 5 mg/5 mL Syrup 60ml 065166 PKR 45.83 PKR 0.76/mL 🔒 Pharma Pro
Oflonim Ofloxacin 0.3 % Ophthalmic drops 5ml 072379 PKR 120.08 PKR 24.02/mL 🔒 Pharma Pro
PIPRAL-T Piperacillin + tazobactam 4 g + 0.5 g IV injection 1's 117576 PKR 827.11 PKR 827.11/vial/unit 🔒 Pharma Pro
PIPRAL-T Piperacillin + tazobactam 2 g + 0.25 g IV injection 1's 117825 PKR 363.80 PKR 363.80/vial/unit 🔒 Pharma Pro
Piprocap Ciprofloxacin 250 mg Capsule 10's 066698 PKR 195.13 PKR 19.51/capsule 🔒 Pharma Pro
Piprocap Ciprofloxacin 500 mg Capsule 10's 066699 PKR 322.71 PKR 32.27/capsule 🔒 Pharma Pro
Piprocap Ciprofloxacin 2 mg IV infusion 100ml 072389 PKR 204.13 PKR 2.04/mL 🔒 Pharma Pro
Piprocap Ciprofloxacin 2 mg/mL IV infusion 50ml 072389 PKR 90.06 PKR 1.80/mL 🔒 Pharma Pro
Relyon Artemether + Lumefantrine 20 mg + 120 mg Tablet 2 x 8's 054555 PKR 480.31 PKR 30.02/tablet 🔒 Pharma Pro
Relyon Artemether 80 mg Injection 1mlx6's 072386 PKR 900.58 PKR 150.10/mL 🔒 Pharma Pro
Relyon Artemether 80 mg/mL Injection 5'sx1ml 072386 PKR 720.46 PKR 144.09/mL 🔒 Pharma Pro
Relyon Artemether 80 mg Injection 1mlx1's 072386 PKR 150.10 PKR 150.10/mL 🔒 Pharma Pro
A to Z

All 33 Nimrall Laboratories brands in Pakistan

  • Adin Loratadine · 10 mg tablet, 5 mg/5 mL syrup
  • Aquanim Water Water for Injection · 5 mL injection
  • Azotine Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 500 mg capsule
  • Bi-cip Ciprofloxacin · 250 mg tablet, 250 mg/5 mL suspension, 500 mg tablet
  • Cefine Cefixime · 100 mg/5 mL suspension, 400 mg capsule
  • Clyclomed Cyclopentolate · 1 % drops, 1% drops
  • Exil w / w Terbinafine · 1 % cream
  • Fosine Miltefosine · 50 mg capsule
  • Glantan Eye Latanoprost · 0.0525 mg/mL drops
  • Goldspec Moxifloxacin · 400 mg tablet
  • Grell Clopidogrel · 75 mg tablet
  • Hydronim Hydroxychloroquine · 200 mg tablet
  • Klar-500 Clarithromycin · 500 mg capsule
  • Levox Levofloxacin · 250 mg tablet, 500 mg tablet
  • Lopenim 200 Lopinavir + Ritonavir · 200 mg + 50 mg tablet
  • Lumen Fluconazole · 50 mg/5 mL suspension
  • Lunim Fluconazole · 2 mg/mL infusion
  • Mepra 20 Omeprazole · 20 mg capsule
  • Mero-M Meropenem · 1 g injection, 500 mg injection
  • Metzyle Metronidazole (Benzoate), Metronidazole · 200 mg suspension, 500 mg infusion
  • Nimolol Timolol · 0.5 % drops
  • Nimstat Nystatin · 100,000 IU tablet
  • Nimzine Cetirizine · 10 mg tablet, 5 mg/5 mL syrup
  • Oflonim Ofloxacin · 0.3 % drops
  • PIPRAL-T Piperacillin + tazobactam · 2 g + 0.25 g injection, 4 g + 0.5 g injection
  • Piprocap Ciprofloxacin · 2 mg infusion, 2 mg/mL infusion, 250 mg capsule
  • Relyon Artemether + Lumefantrine, Artemether · 20 mg + 120 mg tablet, 80 mg injection, 80 mg/mL injection
  • Ribkon 400 Ribavirin · 400 mg capsule
  • Savion Silver sulfadiazine · 1 % cream, 10 mg/g (1%) cream
  • Telizo Ceftriaxone · 1 g injection, 250 mg injection
  • Tesco Ibuprofen · 200 mg tablet, 400 mg tablet
  • Viklar-500 Clarithromycin · 500 mg tablet
  • Vitamika Amikacin · 50 mg injection
Questions

Nimrall Laboratories: common questions

How many products does Nimrall Laboratories have in Pakistan?

Nimrall Laboratories has 62 registered medicine presentations in Pakistan, sold under 33 brands and covering 32 generic medicines.

What are the main brands of Nimrall Laboratories?

By number of registered strengths and packs, its largest brands are Piprocap (Ciprofloxacin), Relyon (Artemether + Lumefantrine, Artemether), Savion (Silver sulfadiazine), Telizo (Ceftriaxone) and Tesco (Ibuprofen). This is not a sales ranking.

Which therapy areas does Nimrall Laboratories cover?

The most products are in Anti-infectives (46), Respiratory & allergy (4), Ophthalmology (4), Pain & musculoskeletal (4) and Fluids & supportive care (2).

Where can I see Nimrall Laboratories medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Nimrall Laboratories — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 11, 2026, from https://medinfobase.com/company/nimrall-laboratories/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9